TB is the world’s deadliest infectious disease

Every $1 invested in TB yields a $42 return in economic benefit for TB affected countries, with significant positive impact on national GDPs.

changing how we do BUSINESS in TB and global health

Current approaches and systems cannot efficiently and effectively achieve our targets and goals nor address future TB and global health challenges

What are Rtc’s Superpowers?

We thrive on taking bold and smart risks to challenge the status quo

SUPPORTED BY

The mark ‘CDC’ is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise.